Ralf Kircheis

7PUBLICATIONS
1CO-AUTHORS
Innate immunityBiomolecular modelling and designMedical infection agents (incl. prions)Nanotoxicology, health and safetyElectrical energy generation (incl. renewables, excl. photovoltaics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 16, 2026
Special Issue "The Role of Toll-like Receptors (TLRs) in Infection and Inflammation: Third Edition".

|Jun 26, 2026
In Silico Modeling of Structural Compatibility and Alignment Between Viral Class I Fusion Cores and Human TLR4/MD-2.

|May 25, 2024
In Silico Analyses Indicate a Lower Potency for Dimerization of TLR4/MD-2 as the Reason for the Lower Pathogenicity of Omicron Compared to Wild-Type Virus and Earlier SARS-CoV-2 Variants.

Ralf Kircheis

|Apr 13, 2023
The Role of Toll-like Receptors (TLRs) and Their Related Signaling Pathways in Viral Infection and Inflammation.

Ralf Kircheis, Oliver Planz

|Jun 10, 2022
Could a Lower Toll-like Receptor (TLR) and NF-κB Activation Due to a Changed Charge Distribution in the Spike Protein Be the Reason for the Lower Pathogenicity of Omicron?

Ralf Kircheis, Oliver Planz

|Oct 13, 2021
Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling Pathways.

Ralf Kircheis

Pageof 2

Frequent Collaborators

3 joint publications

Oliver Planz